Back

Discussion - Biomarker guidance to start remote patient management in heart failure.

26 May 2019 (09:45 - 09:48)
Organised by:
Congress Presentation Part of: Late breaking trial II - Chronic heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2019

12 More presentations in this session

Presentation thumbnail
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial
Professor M. Schulz (Leipzig, DE)
Slides Video
Presentation thumbnail
Discussion - PHARM-CHF
Video
Presentation thumbnail
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure
Professor P. Rossignol (Monaco, MC)
Slides Video
Presentation thumbnail
Discussion - AMBER.
Video
Presentation thumbnail
Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial
Doctor A. Biolo (Porto Alegre, BR)
Slides Video

Access the full session

Session thumbnail
Late breaking trial II - Chronic heart failure

The Event

Event poster

Heart Failure 2019

26 May 2019 09:45 CET
You may be interested in
thumbnail
Congress Session
Patient remote monitoring: a paradigm shift in the management of heart failure patients
26 August 2023
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Optimising heart failure care; real world outcomes from algorithm-based remote monitoring and digital pathway transformation
13 April 2026
thumbnail
Congress Session
HFpEF: modern approaches to diagnosis and management
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources